🔗 Share this article

An underground economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Investigational Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Followers are encouraged to message these accounts privately for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a robust trade exists on messaging services, where groups with numerous of members share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Professionals Voice Concerns

Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is worrisome and could result in individuals injecting substances of unknown origin.

Some experts said the demand for the experimental drug could be linked to the rising cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the British medical regulations.

Some influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and customer regulations, potentially leading to fines, prosecution or prison.

Platform Reaction and Material Removal

Based on TikTok, the platform has removed violative content and prohibited associated keywords and query recommendations. The company said it was committed to keeping the service secure and allocating resources in enhancing enforcement strategies.

Digital Marketplace Activities

Investigations also found communities with up to nine thousand participants marketing the experimental drug using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly brings up channels with numerous of members, filled with photos of slimming results, glowing testimonials and detailed instructions for mixing or administering at home.

Within moments of entering one group, a vendor posted WhatsApp details, where the majority of transactions take place. The vendor provided an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about body mass, medical conditions or past usage.

Item Information and Pricing

Within these communities, posts display black plastic packages with Royal Mail stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with sterile water, or ready-to-use injectors typically priced at £160 for 20 milligrams. When asked how much time a injector should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram said it regularly monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering substances they cannot confirm. Even if the research behind retatrutide is sound, these digital versions may not include what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has already encountered individuals harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company investigational product not yet approved … may expose users to potentially significant medical dangers”.